CertHub Raises €6.2M to Tackle Medtech’s Compliance Bottleneck

Why It Matters

By slashing compliance costs and timelines, CertHub enables faster market entry for life‑saving devices, reshaping the medtech value chain. The investment also signals growing confidence in AI‑based regulatory automation across Europe and beyond.

Key Takeaways

• €6.2M seed round led by Cusp Capital
• AI platform cuts documentation time up to 60%
• Certification costs drop from €4M to €1.6M
• Notified Bodies gain faster, standardized reviews
• Expansion plans target US and Brazil markets

Pulse Analysis

Regulatory pressure on European medtech firms has reached a tipping point, with 70% of manufacturers citing burdensome compliance and an industry‑wide cost estimate of €12 billion for new requirements. Traditional certification pathways demand five years and more than €4 million in labor‑intensive documentation, stifling innovation and delaying patient access to advanced therapies. This environment has created fertile ground for technology solutions that can streamline and digitize the approval process.

CertHub’s AI‑first platform tackles these challenges by automating technical documentation, quality‑system records, and audit preparation. Early adopters report up to 60% savings in both time and cost, translating into a €2.4 million reduction per certification cycle. The system also delivers higher‑quality, standardized dossiers to Notified Bodies, enabling quicker, more predictable review cycles. By shifting focus from paperwork to product development, manufacturers can accelerate R&D pipelines while maintaining rigorous regulatory standards.

The recent €6.2 million funding round, led by Cusp Capital and supported by industry veterans, equips CertHub to scale across Europe and extend integrations with Notified Bodies. Plans include jurisdiction packs for the United States and Brazil, positioning the startup as a global compliance facilitator. Long‑term, CertHub aims to create a shared compliance infrastructure and a comprehensive dataset on certification outcomes, paving the way for predictive compliance analytics and data‑driven product approvals that could redefine the medtech landscape.